Takeshi Kimura
Kyoto University, Graduate School of Medicine · Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine · Professor of Medicine, Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Takeshi Kimura as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:18 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05347069 · Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without RevascularizationTakeshi Morimoto · recruiting · Stable Angina Pectoris, Coronary Artery Disease, Ischemic Heart Disease · principal investigator
- Ph4NCT04724460 · Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With CancerTakeshi Morimoto · completed · Venous Thrombosis, Neoplasms, Anticoagulants · principal investigator
- Ph4NCT04691700 · GOREISAN for Heart Failure (GOREISAN-HF) TrialTakeshi Morimoto · active not recruiting · Heart Failure, Edema, Traditional Japanese Medicine · study chair
- Ph4NCT04609111 · ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 StudyKyoto University, Graduate School of Medicine · unknown · Acute Coronary Syndrome · principal investigator
- Ph4NCT03895502 · Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer StudyTakeshi Morimoto · completed · Venous Thrombosis, Neoplasms, Anticoagulant · study chair
- Ph4NCT03462498 · ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACSKyoto University, Graduate School of Medicine · unknown · Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease · principal investigator
- Ph4NCT02619760 · ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 StudyKyoto University, Graduate School of Medicine · completed · Coronary Artery Disease · study chair
- N/ANCT02334891 · Kyoto Congestive Heart Failure StudyKyoto University, Graduate School of Medicine · completed · Congestive Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic · principal investigator
- Ph4NCT01962545 · Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) StudySatoshi Shizuta · completed · Atrial Fibrillation, Coronary Artery Disease · principal investigator
- N/ANCT01844284 · AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese PopulationAbbott Medical Devices · completed · Coronary Artery Disease, Myocardial Ischemia · principal investigator
- Ph4NCT01659034 · Short and Optimal Duration of Dual Antiplatelet Therapy StudyTakeshi Morimoto · completed · Coronary Artery Disease · principal investigator
- Ph4NCT01303640 · NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent TrialTakeshi Morimoto · completed · Coronary Artery Disease · principal investigator
- Ph4NCT01230216 · Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular UltrasoundTakeshi Morimoto · terminated · Coronary Artery Disease, Hypertension · principal investigator
- N/ANCT01187823 · The Effect of Adaptive Servo Ventilation and Oxygen Therapy in Central Sleep Apnea PatientsKyoto University, Graduate School of Medicine · completed · Chronic Heart Failure, Sleep Apnea · principal investigator
- Ph4NCT01155635 · Carvedilol Post-intervention Long-term Administration in Large-scale TrialTakeshi Morimoto · completed · Myocardial Infarction · principal investigator
- Ph4NCT01123291 · Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention TrialTakeshi Morimoto · completed · Coronary Artery Disease · principal investigator
- Ph4NCT01069302 · Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in JapanTakeshi Morimoto · completed · Coronary Artery Disease · principal investigator
- Ph4NCT01035450 · Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent TrialTakeshi Morimoto · completed · Coronary Artery Disease · principal investigator
- Ph4NCT00733161 · Effect of Passive Exercise on Systemic Endothelial Function in Elderly Patients With Chronic Heart FailureKyoto University · completed · Congestive Heart Failure, Endothelium-derived Factors, Elderly · principal investigator
- Ph4NCT00242944 · Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)Kyoto University · completed · Coronary Disease, Hypercholesterolemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:18 UTC. The ranking covers the 200 most relevant of 473 PubMed records, and a shared surname and initials can bring in a namesake. All 473 on PubMed
- 1,032 citationsRCR 41.1
- 736 citationsRCR 32.0
- 302 citationsRCR 9.5
- 285 citationsRCR 22.9
- Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.Respirology · 2008209 citationsRCR 7.0
- MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.Cancer Prev Res (Phila) · 2013206 citationsRCR 5.0
- Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans.J Agric Food Chem · 2007201 citationsRCR 6.6
- High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.Circulation · 2018196 citationsRCR 8.1
- Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).J Clin Oncol · 2021194 citationsRCR 9.4
- 175 citationsRCR 7.4